Bristol-Myers Squibb to Present at J.P. Morgan Healthcare Conference

01/03/2018

Bristol-Myers Squibb Company (NYSE: BMY) will present at the J.P. Morgan Healthcare Conference on Tuesday, January 9, 2018, in San Francisco. Giovanni Caforio, chairman and chief executive officer, will make a formal presentation about the company at 10 a.m. PST (1 p.m. EST).

Investors and the general public are invited to listen to a live webcast of the presentation at http://investor.bms.com. Materials related to the presentation will be available at the same website at the start of the live webcast. An archived edition of the presentation will be available later that day.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedInTwitter, YouTube and Facebook.

Bristol-Myers Squibb Media: Ken Dominski, 609-252-5251 ken.dominski@bms.com or Investors: John Elicker, 609-252-4611 john.elicker@bms.com orTim Power, 609-252-7509 timothy.power@bms.com orBill Szablewski, 609-252-5894 william.szablewski@bms.com

Multimedia Files:

Categories: Press Releases